Lipella Pharmaceuticals (LIPO) Stock Chart & Stock Price History $0.60 0.00 (-0.03%) As of 12:08 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lipella Pharmaceuticals Stock Price Performance The Lipella Pharmaceuticals (LIPO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 83.10%, with a year-to-date return of -80.41%. In the past month, the stock has decreased 25.31%, reflecting recent market activity. As of the latest close, Lipella Pharmaceuticals traded at $0.60 with a market cap of $2.67 million and volume of 727 shares. Receive LIPO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lipella Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-5.16%1 Month Performance-25.31%3 Month Performance-79.61%Year-To-Date Performance-80.41%1 Year Performance-83.10% LIPO Stock Chart for Thursday, August, 21, 2025 LIPO Chart by TradingView Lipella Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/20/2025$0.59$0.60+1.12%$0.60$0.59727 shs$2.67 million08/19/2025$0.59$0.59$0.60$0.579,771 shs$2.64 million08/18/2025$0.63$0.59-6.17%$0.63$0.599,322 shs$2.64 million08/15/2025$0.63$0.63$0.64$0.63741 shs$2.81 million08/14/2025$0.63$0.63-0.38%$0.63$0.63754 shs$2.81 million08/13/2025$0.64$0.63-0.41%$0.64$0.631,861 shs$2.83 million08/12/2025$0.60$0.64+5.85%$0.64$0.60570 shs$2.84 million08/11/2025$0.57$0.60+6.18%$0.64$0.5615,368 shs$2.68 million08/08/2025$0.60$0.57-6.07%$0.60$0.555,644 shs$2.52 million08/07/2025$0.62$0.60-3.61%$0.65$0.5719,315 shs$2.69 million Get the Latest News and Ratings for LIPO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lipella Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/06/2025$0.65$0.62-4.00%$0.64$0.621,743 shs$2.79 million08/05/2025$0.67$0.65-3.16%$0.70$0.654,766 shs$2.90 million08/04/2025$0.71$0.67-5.46%$0.71$0.674,583 shs$3.00 million08/01/2025$0.70$0.71+1.28%$0.71$0.691,604 shs$3.17 million07/31/2025$0.71$0.70-1.27%$0.73$0.704,125 shs$3.13 million07/30/2025$0.71$0.71$0.71$0.71191 shs$3.17 million07/29/2025$0.69$0.71+2.75%$0.74$0.691,411 shs$3.17 million07/28/2025$0.63$0.69+10.21%$0.78$0.6510,113 shs$3.09 million07/25/2025$0.72$0.63-12.92%$0.80$0.635,193 shs$2.80 million07/24/2025$0.70$0.72+2.71%$0.72$0.681,290 shs$3.22 million07/23/2025$0.73$0.70-3.97%$0.73$0.704,860 shs$3.13 million07/22/2025$0.80$0.73-8.75%$0.75$0.732,413 shs$3.26 million07/21/2025$0.75$0.80+6.67%$0.80$0.735,706 shs$3.57 million Related Companies GOVX Stock Chart CSCI Stock Chart PHXM Stock Chart IMCC Stock Chart HOOK Stock Chart FLGC Stock Chart LGVN Stock Chart SNPX Stock Chart PHIO Stock Chart BCDA Stock Chart Receive LIPO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lipella Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LIPO) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lipella Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lipella Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access